Heading Into Earnings, Expectations Are Rising For These 4 Biotech Stocks
Heading into an earnings season in which many companies will be posting much lower earnings as a result of the pandemic.
3 Newly Listed Biotech Stocks – And A Look At Their Market Debuts
Three biotech companies developing therapies for the treatment of cancer and other diseases – including infectious diseases like COVID-19 – began trading on Friday.
Early Performance Of 3 Newly Listed Biotech Stocks
A trio of biotech firms IPOed on Friday – and saw double-digit gains on their trading debuts.
A Friday Flurry Of Biotech IPOs
A look at the four biotech companies going public Friday – which include two firms developing small molecule therapies to treat cancer.
3 High-Risk, High-Reward Biotech Stocks With “Millionaire-Maker Potential”
“Make no mistake: These stocks are risky. Nonetheless, each of these companies has a few factors in its favor aside from being popular with retail traders, so if you’re looking for a high-risk and high-reward stock to add to your portfolio, one of these might be worth buying,”
2 Small-Cap Contenders For The Next Big Biotech Gainers
Which biotech stocks will be the next to reward risk-tolerant investors with massive returns?
From COVID Or Other Catalysts, These 5 Biotech Stocks Could See Massive Gains In The Coming Months
“The health care sector, some biotech stocks in particular, are looking to explode in 2021,” declares the author of today’s article, who further notes that “There have been some breakout companies as a result of the coronavirus pandemic, but other catalysts will be playing into the expected gains as well.”
Which Of These Biotech Penny Stocks Are Worth The Under-$4 Price Of Admission?
The four penny stocks highlighted in today’s article are all biopharmaceutical/biotech companies, they can all be bought for under $4, and they all have important upcoming events.
The Worst Month’s Worst Stocks
“September has historically been the worst-performing month for stocks – and today’s article identifies the stocks that have shown themselves to be the worst stocks to own in September over the past 10 years.
ETFs To Consider As Small-Cap Biotechs Make “Their Presence Felt In Every Area”
“Be it COVID vaccine or cancer research, small-cap biotech companies are making their presence felt in every area,”